Accelerate Diagnostics Cash Flow - Annual (NASDAQ:AXDX)

Add to My Stocks
$23.1 $0.45 (1.91%) AXDX stock closing price Mar 29, 2017 (Closing)

The Accelerate Diagnostics cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Accelerate Diagnostics profits one has to check the income statement and for Accelerate Diagnostics debt one has to check the balance sheet. Accelerate Diagnostics cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents.  Accelerate Diagnostics had cash and cash equivalents of $53.56M at the beginning of the year and $120.58M at year end for 2015.   The cash from operating activities for Accelerate Diagnostics is $-35.12M for 2015, which saw a decrease of 87.01% from previous year. View details of Accelerate Diagnostics cash flows for latest & last ten financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007
Accelerate Diagnostics Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.98M1.15M0.43M-0.06M0.06M0.06M0.06M0.07M
Net Increase (Decrease) in Assets Liabilities-1.36M1.25M--0.01M-0.16M0.04M-0.06M0.16M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net8.38M9.62M3.83M-0.27M-0.01M-0.14M-0.01M
Accelerate Diagnostics Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-3.65M-1.93M-1.15M------
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments0.98M-1.43M-12.01M-----0.01M-
Other Cash Inflow (Outflow) from Investment Activities-----0.08M-0.01M-0.08M-0.07M-0.11M
Accelerate Diagnostics Net Cash from (used by) Invesment Activities
Issuance (Purchase) of Equity Shares104.97M45.79M40.88M------
Issuance (Repayment) of Debt Securities-0.14M-0.1M-------
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities
Accelerate Diagnostics Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Accelerate Diagnostics Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year53.56M30.02M12.06M-0.77M0.28M0.86M1.23M1.39M
Cash & Equivalents at Year End120.58M53.56M30.02M-0.58M0.22M0.47M1.08M1.02M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Cash flow for another ticker

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Accelerate Diagnostics stock price history and Accelerate Diagnostics stock comparison chart inevitably reflect its cash flow situation.
  • Net Change in Cash and Cash Equivalents: Accelerate Diagnostics cash reduced YoY to $-45.49M, meaning the company is unable to meet its expenditure and grow cash which will also eventually reflect in the Accelerate Diagnostics stock price movement.
  • The cash generated from the core business or operations was negative at $-35.12M for Accelerate Diagnostics in the latest year. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-2.67M for AXDX stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Accelerate Diagnostics earned $59.13M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Accelerate Diagnostics Cash Flow

FCF margin